Others
others
Research Areas
- Actin(12)
- Inhibitory Antibodies(174)
- Adenylate cyclase(29)
- AhR(13)
- Aldose reductase(26)
- Arginase(13)
- AT Receptors(1)
- Autotaxin(4)
- ATP citrate lyase (10)
- BCRP(15)
- ROR/RAR/RXR(92)
- Caged Compounds(3)
- Calmodulin protein kinase II(1)
- CaM kinase II(9)
- Carbonic Anhydrase(28)
- Cell Penetrating Peptide(2)
- Ceramidases(4)
- CERK(1)
- Collagen proline hydroxylase(1)
- COMT(11)
- Cytokine(4)
- dCTP Pyrophosphatase(1)
- DHODH(1)
- Diacylglycerol Kinase(1)
- DNA Stain(17)
- eIF2a(2)
- Endopeptidase(3)
- Enzyme Substrates / Activators(69)
- ES-FLI1/RHA(2)
- Farnesyl Diphosphate Synthase(1)
- FBPase(4)
- FLAP(10)
- Fluorescent Probes(305)
- GLI(4)
- Glycoprotein(5)
- Glycosylase(5)
- Saccharides and Glycosides(17)
- Glyoxalase I(1)
- GSNOR(2)
- Guanylate Cyclase (29)
- Guanylyl Cyclase(7)
- Gutathione S-transferase(12)
- Heme oxygenase(10)
- Hexokinase(6)
- Hydroxylases(10)
- IL Receptor(1)
- Imidazoline Receptors(18)
- IMPDH(1)
- Inositol Phosphatases(4)
- Lp-PLA2(1)
- LpxC(1)
- Matrix Metalloprotease(1)
- MDR multidrug resistance(44)
- Menin-MLL(5)
- MGMT(1)
- Mineralocorticoid Receptor(23)
- Miscellaneous Compounds(9)
- MyD88(9)
- Myosin(25)
- NAE(2)
- NADPH Oxidase(16)
- Nampt(27)
- Natriuretic Peptide Receptors(4)
- Nitric Oxide(74)
- Nuclear Receptors(13)
- Oxygenases/Oxidases(5)
- PDHK(10)
- PGC-1α(5)
- Pregnane X Receptors(2)
- Reductases(6)
- Renin(12)
- Retinoid X Receptors(11)
- Squalene epoxidase(4)
- SGK(11)
- sFRP-1(3)
- SPHK(18)
- Synthases/Synthetases(12)
- Tachykinin(6)
- Thrombopoietin Receptor(7)
- Thymidine phosphorylase(4)
- Transcription Factors(118)
- Transketolase(3)
- β(1,3)-D-Glucan Synthase(2)
- β-Lactamase(3)
- XAO(4)
- Others(1570)
- BMI-1(1)
- SOD(8)
- Homodimerizers(2)
- Renal Diseases(9)
- FAS(24)
- calmodulin(3)
- Protein synthesis(4)
- Epac(1)
- MAGL(19)
- exocytosis(1)
- peroxiredoxins(1)
- Glucosidase(47)
- Estrogen Receptor/ERR(175)
- Progesterone Receptor(37)
- Cyclase(6)
- Environmental Toxicology(241)
- Glycerolipid Lipases(15)
- Lipases(26)
- Multidrug-Resistance Proteins(8)
- Negative Controls(9)
- Nucleic Acid Turnover/Signaling(56)
- Organ- & System-Specific Toxicity(157)
- Pesticides(102)
- Pharmaceutical Impurities(35)
- Sulfotransferases(4)
- Tec(3)
- Toxicology(161)
- Xenobiotic Sensing(23)
- UDP Glucuronosyltransferases(46)
- Amino Acid Derivatives(43)
- Drug Intermediate(244)
- Drug Isomer(57)
- Insecticide(14)
- MOFs(329)
- Phytohormone(7)
- SHMT(4)
- Phosphoramidites(24)
Products Related to Others(4260)
- GC73084Borocaptate sodiumCAS: 144885-51-8Purity: >96.00%
Borocaptate sodium is a boron-containing compound that can be used as a therapeutic agent in boron neutron capture therapy (BNCT), exhibiting anticancer activity.
- GC73089(2R)-VildagliptinCAS: 1036959-27-9Purity: >99.00%
(2R)-Vildagliptin is the isomer of Vildagliptin , and can be used as an experimental control.
- GC73091Necrocide 1CAS: 1247028-61-0Purity: >98.50%
Necrocide 1 (compound (S)-38) a potent anticancer agent.
- GC73092(R)-Necrocide 1CAS: 1247028-62-1Purity: >99.00%
(R)-Necrocide 1 (compound (R)-38) a potent anticancer agent.
- GC73104(S,S)-CPI-1612CAS: 2374971-82-9Purity: >99.00%
(S,S)-CPI-1612 is the isomer of CPI-1612 , and can be used as an experimental control.
- GC73117(3R,10R,14aS)-AZD4625
(3R,10R,14aS)-AZD4625 is the isomer of AZD4625 , and can be used as an experimental control.
- GC73167Ganglioside GM2CAS: 127663-77-8Purity: >98.00%
Ganglioside GM2 is a human tumor antigen (OFA-I-1).
- GC73216KDM5B-IN-4Purity: >99.00%
KDM5B-IN-4 (compound 11ad) is a lysine demetlase 5B (KDM5B) inhibitor with an IC50 of 0.025 μM KDM5B-IN-4 increases substrate H3K4me1/2/3 level by inhibiting KDM5B in PC-3 cells.
- GC73265ARUK2007145Purity: >98.00%
ARUK2007145 is potent, cell-active dual inhibitor of the PI5P4Kα and PI5P4Kγ isoforms (pIC50: 7.3 and 8.1, respectively).
- GC73285NR2F1 agonist 1CAS: 374101-64-1Purity: >99.00%
NR2F1 agonist 1, a nuclear receptor NR2F1 agonist, specifically activates dormancy programs in malignant cells.
- GC73316AIMP2-DX2-IN-1CAS: 848256-17-7Purity: >98.00%
AIMP2-DX2-IN-1 (Compound 35) is a potent AIMP2-DX2 inhibitor with an IC50 of 0.1063 μM.
- GC73341LPA5 antagonist 2CAS: 2839471-44-0Purity: >99.00%
LPA5 antagonist 2 (compound 65) is a high aqueous solubility LPA5 (lysophosphatidic acid receptor 5) antagonist.
- GC73343RUNX1/ETO tetramerization-IN-1CAS: 88755-39-9Purity: >99.00%
RUNX1/ETO tetramerization-IN-1 is a small-molecule inhibitor of RUNX1/ETO tetramerization, exhibits anti-leukemic effect.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC73084 | Borocaptate sodium | 144885-51-8 | >96.00% | |
Borocaptate sodium is a boron-containing compound that can be used as a therapeutic agent in boron neutron capture therapy (BNCT), exhibiting anticancer activity. | ||||
| GC73089 | (2R)-Vildagliptin | 1036959-27-9 | >99.00% | |
(2R)-Vildagliptin is the isomer of Vildagliptin , and can be used as an experimental control. | ||||
| GC73091 | Necrocide 1 | 1247028-61-0 | >98.50% | |
Necrocide 1 (compound (S)-38) a potent anticancer agent. | ||||
| GC73092 | (R)-Necrocide 1 | 1247028-62-1 | >99.00% | |
(R)-Necrocide 1 (compound (R)-38) a potent anticancer agent. | ||||
| GC73097 | SPH5030 | 2364326-23-6 | >99.00% | |
SPH5030 is a selective and irreversible HER2 inhibitor. | ||||
| GC73102 | VD2173 epimer-1 | - | >95.00% | |
VD2173 epimer-1 is a racemic mixture of VD2173. | ||||
| GC73104 | (S,S)-CPI-1612 | 2374971-82-9 | >99.00% | |
(S,S)-CPI-1612 is the isomer of CPI-1612 , and can be used as an experimental control. | ||||
| GC73116 | (R)-FT709 | 2413991-75-8 | >97.00% | |
(R)-FT709 is an active compound. | ||||
| GC73117 | (3R,10R,14aS)-AZD4625 | - | - | |
(3R,10R,14aS)-AZD4625 is the isomer of AZD4625 , and can be used as an experimental control. | ||||
| GC73167 | Ganglioside GM2 | 127663-77-8 | >98.00% | |
Ganglioside GM2 is a human tumor antigen (OFA-I-1). | ||||
| GC73181 | HQ005 | 2750644-31-4 | - | |
HQ005 is a potent CCNK degrader with an DC50 value of 0.041 µM. | ||||
| GC73185 | KH-4-43 | 2813310-07-3 | >99.00% | |
KH-4-43 is an inhibitor of E3 CRL4. | ||||
| GC73206 | AzGGK TFA | - | >99.00% | |
AzGGK TFA is an unnatural amino acid. | ||||
| GC73216 | KDM5B-IN-4 | - | >99.00% | |
KDM5B-IN-4 (compound 11ad) is a lysine demetlase 5B (KDM5B) inhibitor with an IC50 of 0.025 μM KDM5B-IN-4 increases substrate H3K4me1/2/3 level by inhibiting KDM5B in PC-3 cells. | ||||
| GC73235 | Berubicin | 677017-23-1 | >87.00% | |
Berubicin (RTA 744 free base; WP 744) is a 4'-O-benzyldoxorubicin that inhibits P-gp and MRP1-mediated efflux and has anticancer activity. | ||||
| GC73239 | KB-05 | 1956368-15-2 | >95.00% | |
KB-05 is an electrophilic fragment molecule that can be used in DIA-based quantitative chemical proteomic screening studies. | ||||
| GC73265 | ARUK2007145 | - | >98.00% | |
ARUK2007145 is potent, cell-active dual inhibitor of the PI5P4Kα and PI5P4Kγ isoforms (pIC50: 7.3 and 8.1, respectively). | ||||
| GC73285 | NR2F1 agonist 1 | 374101-64-1 | >99.00% | |
NR2F1 agonist 1, a nuclear receptor NR2F1 agonist, specifically activates dormancy programs in malignant cells. | ||||
| GC73293 | And1-IN-1 | 2451028-69-4 | >98.00% | |
And1-IN-1 (compound III) is a potent And1 inhibitor. | ||||
| GC73302 | GNE-235 | - | >98.00% | |
GNE-235 is a compound selective for the second bromodomain of PBRM1, with a KD of 0.28 ± 0.02 μM. | ||||
| GC73314 | AS1134900 | 149760-98-5 | >98.50% | |
AS1134900 is a highly selective, allosteric and uncompetitive NADP+-dependent malic enzyme 1 (ME1) inhibitor. | ||||
| GC73316 | AIMP2-DX2-IN-1 | 848256-17-7 | >98.00% | |
AIMP2-DX2-IN-1 (Compound 35) is a potent AIMP2-DX2 inhibitor with an IC50 of 0.1063 μM. | ||||
| GC73341 | LPA5 antagonist 2 | 2839471-44-0 | >99.00% | |
LPA5 antagonist 2 (compound 65) is a high aqueous solubility LPA5 (lysophosphatidic acid receptor 5) antagonist. | ||||
| GC73343 | RUNX1/ETO tetramerization-IN-1 | 88755-39-9 | >99.00% | |
RUNX1/ETO tetramerization-IN-1 is a small-molecule inhibitor of RUNX1/ETO tetramerization, exhibits anti-leukemic effect. | ||||